Long-term efficacy of boosted and unboosted atazanavir-containing regimens: results from the SCOLTA Project
Tiziana Quirino(Ospedale di Circolo di Busto Arsizio), Paolo Bonfanti(University of California San Diego), Loredana Palvarini, P Marconi, Giancarlo Orofino(Ospedale Amedeo di Savoia), Francesca Vichi, Giuseppe Vittorio De Socio(University of Perugia), Elena Ricci(Mario Negri Institute for Pharmacological Research), Canio Martinelli(Azienda Ospedaliero-Universitaria Careggi), Elena Rosella, Barbara Menzaghi(Ospedale di Circolo di Busto Arsizio), Giordano Madeddu(University of Sassari), Giovanni Francesco Pellicanò(University of Messina), Giovanni Penco(Ente Ospedaliero Ospedali Galliera), R Giuntini(Azienda Ospedaliero-Universitaria Careggi), Erika Gianelli(Luigi Sacco Hospital), C. Grosso, Silvia Carradori(Azienda Ospedaliero-Universitaria Careggi)
Cited by 1
Related Papers
Hospital-Acquired Infections in Critically Ill Patients With COVID-19
|CHEST Journal|2021|404
High rates of 30-day mortality in patients with cirrhosis and COVID-19
|Journal of Hepatology|2020|394
Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase–Producing <i>K. pneumoniae</i> Infections: A Retrospective Observational Multicenter Study
|Clinical Infectious Diseases|2021|264
Magnitude and Dynamics of the T-Cell Response to SARS-CoV-2 Infection at Both Individual and Population Levels
|medRxiv|2020|234
Assessment, Diagnosis, and Treatment of HIV-Associated Neurocognitive Disorder: A Consensus Report of the Mind Exchange Program
|Clinical Infectious Diseases|2012|208